National Advisory Council on Migrant Health; Notice of Meeting, 2058 [E6-171]
Download as PDF
<![CDATA[
erjones on PROD1PC68 with NOTICES
2058
Federal Register / Vol. 71, No. 8 / Thursday, January 12, 2006 / Notices
and met with stakeholders in December
2002 to seek their input.
The guidance was initiated in
response to industry’s request for a
formal dispute resolution process to
resolve differences related to scientific
and technical issues that arise between
investigators and pharmaceutical
manufacturers during FDA inspections.
In addition to encouraging
manufacturers to use currently available
dispute resolution processes, the
guidance describes a formal two-tiered
dispute resolution process that provides
a mechanism for requesting review and
decision on issues that arise during
inspections.
On September 5, 2003 (68 FR 52777),
the FDA announced the availability of
the draft version of this guidance. The
public comment period closed on March
5, 2004. A number of comments were
received, which the agency considered
carefully as it finalized the guidance
and made appropriate changes. The
agency conducted a pilot program with
industry for a 12-month period. During
that time, the agency received one Tier
1 request for dispute resolution and it
was resolved. In addition, FDA met with
representatives from industry trade
associations in September 2004, near
the end of the pilot period, to discuss
the draft guidance and receive input.
Most of the changes to the guidance
were made to clarify statements in the
draft guidance. The following changes
in the final guidance are noteworthy: (1)
The time period for manufacturers to
ask for clarification of a disputed
scientific or technical issue was
extended from 10 to 30 days; (2) if a
request for formal dispute resolution
reaches the agency’s Dispute Resolution
Panel and is considered appropriate for
review, the panel will schedule a
meeting to discuss the issue within 90
days of the request instead of the
indefinite time period indicated in the
draft guidance; (3) the guidance directs
manufacturers to the Center for Devices
and Radiological Health for disputes
involving combination products when
medical device components are the
focus of the dispute, but clarifies that
disputes solely involving medical
devices are outside the scope of this
guidance; and (4) the guidance clarifies
that, during the dispute resolution
process, a manufacturer may include
relevant information that was not
presented during the inspection, if FDA
determines that a reasonable
explanation was given on why the
information was not presented during
the inspection.
This guidance is being issued
consistent with FDA’s good guidance
practices regulation (21 CFR 10.115).
VerDate Aug<31>2005
15:02 Jan 11, 2006
Jkt 208001
The guidance represents the agency’s
current thinking on formal dispute
resolution: scientific and technical
issues related to pharmaceutical CGMP.
It does not create or confer any rights for
or on any person and does not operate
to bind FDA or the public. An
alternative approach may be used if
such approach satisfies the
requirements of the applicable statutes
and regulations.
II. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) written or electronic
comments regarding this document.
Submit a single copy of electronic
comments or two paper copies of any
mailed comments, except that
individuals may submit one paper copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
III. The Paperwork Reduction Act of
1995
This guidance contains information
collection provisions that are subject to
review by the Office of Management and
Budget (OMB) under the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501–
3520). The collection of information in
this guidance was approved under OMB
control number 0910–0563.
IV. Electronic Access
Persons with access to the Internet
may obtain the guidance document at
the following https://www.fda.gov/cder/
guidance/index.htm or https://
www.fda.gov/ohrms/dockets/
default.htm or https://www.fda.gov/cber/
guidelines.htm or https://www.fda.gov/
cvm/guidance/guidance.html.
Dated: January 4, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6–233 Filed 1–11–06; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
National Advisory Council on Migrant
Health; Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
Name: National Advisory Council on
Migrant Health.
Dates and Times: January 30, 2006, 9 a.m.
to 5 p.m. January 31, 2006, 9 a.m. to 5 p.m.
Place: 5600 Fishers Lane, Conference
Room C, 3rd Floor, Rockville, Maryland
20857.
Status: The meeting will be open to the
public.
Agenda: The agenda includes an overview
of the Council’s general business activities.
The Council will also develop
recommendations to the Secretary of Health
and Human Services. Finally, the Council
will hear presentations from experts on
farmworker issues, including the status of
farmworker health at the local and national
level.
Agenda items are subject to change as
priorities indicate.
For Further Information Contact: Anyone
requiring information regarding the Council
should contact Gladys Cate, Office of
Minority and Special Populations, staff
support to the National Advisory Council on
Migrant Health, Bureau of Primary Health
Care, Health Resources and Services
Administration, 5600 Fishers Lane,
Rockville, Maryland 20857, Telephone (301)
594–0367.
Dated: January 5, 2006.
Tina M. Cheatham,
Director, Division of Policy Review and
Coordination.
[FR Doc. E6–171 Filed 1–11–06; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
E:\FR\FM\12JAN1.SGM
12JAN1
]]>Agencies
[Federal Register Volume 71, Number 8 (Thursday, January 12, 2006)]
[Notices]
[Page 2058]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-171]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
National Advisory Council on Migrant Health; Notice of Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), notice is hereby given of the following
meeting:
Name: National Advisory Council on Migrant Health.
Dates and Times: January 30, 2006, 9 a.m. to 5 p.m. January 31,
2006, 9 a.m. to 5 p.m.
Place: 5600 Fishers Lane, Conference Room C, 3rd Floor,
Rockville, Maryland 20857.
Status: The meeting will be open to the public.
Agenda: The agenda includes an overview of the Council's general
business activities. The Council will also develop recommendations
to the Secretary of Health and Human Services. Finally, the Council
will hear presentations from experts on farmworker issues, including
the status of farmworker health at the local and national level.
Agenda items are subject to change as priorities indicate.
For Further Information Contact: Anyone requiring information
regarding the Council should contact Gladys Cate, Office of Minority
and Special Populations, staff support to the National Advisory
Council on Migrant Health, Bureau of Primary Health Care, Health
Resources and Services Administration, 5600 Fishers Lane, Rockville,
Maryland 20857, Telephone (301) 594-0367.
Dated: January 5, 2006.
Tina M. Cheatham,
Director, Division of Policy Review and Coordination.
[FR Doc. E6-171 Filed 1-11-06; 8:45 am]
BILLING CODE 4165-15-P
